Concordia professor condemns HPV vaccine after winning $270K federal grant to study it

The two types of HPV vaccine now on the market have been shown effective at preventing strains of the virus that cause 70% of cervical cancer, as well as some other cancers.

A Montreal social scientist and the federal agency that awarded her almost $300,000 to study the HPV vaccine are facing criticism after the professor condemned the vaccine and called for a moratorium on its use.

Concordia University’s Genevieve Rail also said there is no proof that the human papillomavirus directly causes cervical cancer, though a German scientist was awarded the Nobel Prize five years ago for discovering the link.

Experts say Rail’s public attacks are seriously misinformed and risk undermining an important public-health program — and they question why the Canadian Institute for Health Research (CIHR) would fund her work. Continue reading Concordia professor condemns HPV vaccine after winning $270K federal grant to study it